Breaking News
6 hours ago
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Abbott gains CE Mark for Libre Duo, the first dual glucose-ketone continuous sensor, with a phased European launch planned for late 2026.
Pharma Now Editorial Team
TIRF medicines discontinued Sept 30, 2024, but REMS obligations persist for all NDA/ANDA holders until applications are formally withdrawn.
Pharma Now Editorial Team

FDA requests removal of the class-wide statin pregnancy contraindication, requiring labeling revisions across all branded and generic statin products.
Pharma Now Editorial Team

Sun Pharma's Phase II laCSCC trial hits 50% response rate, signalling accelerated regulatory filing timelines and biologics manufacturing scale-up demands.
Pharma Now Editorial Team
